Antiviral Activity of Ergoferon against Group A Rotavirus
- Авторлар: Emelianova A.G.1, Shilovskii I.P.2, Sundukova M.S.2, Khaitov M.R.2, Epshtein O.I.1
- 
							Мекемелер: 
							- Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
- State Research Center Institute of Immunology, Federal Medical-Biological Agency
 
- Шығарылым: Том 161, № 6 (2016)
- Беттер: 806-807
- Бөлім: Virology
- URL: https://journals.rcsi.science/0007-4888/article/view/237801
- DOI: https://doi.org/10.1007/s10517-016-3516-x
- ID: 237801
Дәйексөз келтіру
Аннотация
Antiviral activity of Ergoferon was studied in vitro on an experimental model of rotavirus infection in MA-104 cell line. In infected cells treated with Ergoferon, rotavirus titer was shown to decrease by 83 and 90% in comparison with cells treated with solvent used for Ergoferon preparation (p<0.05) and distilled water (p<0.05), respectively. These findings demonstrate high anti-rotavirus activity of Ergoferon.
Авторлар туралы
A. Emelianova
Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
							Хат алмасуға жауапты Автор.
							Email: agemelianova@gmail.com
				                					                																			                												                	Ресей, 							Moscow						
I. Shilovskii
State Research Center Institute of Immunology, Federal Medical-Biological Agency
														Email: agemelianova@gmail.com
				                					                																			                												                	Ресей, 							Moscow						
M. Sundukova
State Research Center Institute of Immunology, Federal Medical-Biological Agency
														Email: agemelianova@gmail.com
				                					                																			                												                	Ресей, 							Moscow						
M. Khaitov
State Research Center Institute of Immunology, Federal Medical-Biological Agency
														Email: agemelianova@gmail.com
				                					                																			                												                	Ресей, 							Moscow						
O. Epshtein
Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
														Email: agemelianova@gmail.com
				                					                																			                												                	Ресей, 							Moscow						
Қосымша файлдар
 
				
			 
						 
						 
						 
					 
						 
									 
  
  
  
  
  Мақаланы E-mail арқылы жіберу
			Мақаланы E-mail арқылы жіберу  Ашық рұқсат
		                                Ашық рұқсат Рұқсат берілді
						Рұқсат берілді Тек жазылушылар үшін
		                                		                                        Тек жазылушылар үшін
		                                					